OptiNose (STU:0OP) 3-Year Revenue Growth Rate : -14.60% (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is OptiNose 3-Year Revenue Growth Rate?

OptiNose's Revenue per Share for the three months ended in Mar. 2024 was €0.12.

During the past 12 months, OptiNose's average Revenue per Share Growth Rate was -19.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -14.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 21.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 9 years, the highest 3-Year average Revenue per Share Growth Rate of OptiNose was 290.00% per year. The lowest was -22.50% per year. And the median was 2.40% per year.

Competitive Comparison of OptiNose's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, OptiNose's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OptiNose's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OptiNose's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where OptiNose's 3-Year Revenue Growth Rate falls into.

OptiNose 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

OptiNose (STU:0OP) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

OptiNose 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of OptiNose's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

OptiNose (STU:0OP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OptiNose Inc (STU:0OP) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

OPTN:USA 0OP:Germany

Address

1020 Stony Hill Road, Suite 300, Yardley, PA, USA, 19067

Website

https://www.optinose.com

OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms (mcg), a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.

OptiNose (STU:0OP) Headlines

No Headlines